Loading
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Latest filing published 20 Oct 2010 for VALEANT PHARMACEUTICALS INTERNATIONAL.
Insider track record
Disclosed buys
2
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
2
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Peter J. Blott: trading record in brief
This profile gathers the share dealings of Peter J. Blott in Valeant Pharmaceuticals International. In total, 9 filings cover trades dated from 30 October 2007 to 28 September 2010.
No open-market sale appears; the market trades are 2 purchases worth €122k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. Besides market trades, the filings include 6 share grants.
The record was last updated on 20 October 2010 with a transaction in Valeant Pharmaceuticals International. The clock since the last published purchase (12 March 2009) now reads 6,434 days. The median gap between a trade and its publication by SEC (Form 4) is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Peter J. Blott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
216,889 sharesCommon StockSEC:0001209191-10-051214:0
436 shares@ US$39.86Common StockSEC:0001209499-10-000038:0
375 shares@ US$31.78Common StockSEC:0001209499-09-000113:0
4,750 shares0Common StockSEC:0001209499-09-000003:0
4,750 shares@ US$16.78Common StockSEC:0001209500-09-000045:0
Canonical exit: 9 Jun 2009 (T+90)
47,600 shares0Common StockSEC:0001209500-09-000023:0
4,100 shares0Common StockSEC:0001209500-08-000015:0
4,100 shares@ US$18.24Common StockSEC:0001209499-08-000139:0
Canonical exit: 12 Feb 2009 (T+90)
25,000 shares@ US$14.80Common StockSEC:0001209499-07-000023:0
9 of 9 declarations
